Prof. Pierre Sirois
Laval University, Canada
Professor
Email: [email protected]
Qualifications
1975 Ph.D. (Pharmacology), University of Sherbrook
1972 M.Sc. (Pharmacology), University of Sherbrooke
1971 B.Sc. (Biology), University of Sherbrooke
1967 B.A., Laval University
Publications (Selected)
-
Li Xiao, Juan-Sebastian Saldivar, Cuilan Zhou, Chengli Chen, Jia Zhang, Pierre Sirois, Kai Li (2009) The updated concept of genome and its implications in biotechnological research and molecular diagnostics. Mol Biotechnol 41: 2. 152-156 Feb
-
L Xiao, J Zhang, Y F Yin, C L Chen, Kai Li, A Chang, P Sirois (2008) Molecular diagnosis of HIV and relevant novel technologies in mutation analysis. Biotechnol Adv 26: 5. 389-397 Sep/Oct
-
Martin Richter, Solange Cloutier, Pierre Sirois (2007) Endothelin, PAF and thromboxane A2 in allergic pulmonary hyperreactivity in mice. Prostaglandins Leukot Essent Fatty Acids 76: 5. 299-308 May
-
Monica C Toffoli, Bichoy H Gabra, Catarina F P Teixeira, Pierre Sirois, Sonia Jancar (2007) Endothelins mediate neutrophil activation, ProMMP-9 release and endothelial cell detachment. Inflammation 30: 1-2. 28-37 Apr
-
Quan Yang, Bruno Battistini, Stéphane Pelletier, Pierre Sirois (2007) Inhibition of basal and stimulated release of endothelin-1 from guinea pig tracheal epithelial cells in culture by beta 2-adrenoceptor agonists and cyclic AMP enhancers. Inflammation 30: 5. 136-147 Oct
-
Richardt G Landgraf, Daniela F Nossi, Pierre Sirois, Sonia Jancar (2007) Prostaglandins, leukotrienes and PAF selectively modulate lymphocyte subset and eosinophil infiltration into the airways in a murine model of asthma. Prostaglandins Leukot Essent Fatty Acids 77: 3-4. 163-172 Oct/Nov
-
Jia Zhang, Y O Wu, Li Xiao, Kai Li, L L Chen, P Sirois (2007) Therapeutic potential of RNA interference against cellular targets of HIV infection. Mol Biotechnol 37: 3. 225-236 Nov
-
P Daull, R Lepage, O Benrezzak, J Cayer, M Beaudoin, K Belleville, A Blouin, P Sirois, F Nantel, A Y Jeng, B Battistini (2006) The first preclinical pharmacotoxicological safety assessment of CGS 35601, a triple vasopeptidase inhibitor, in chronically instrumented, conscious, and unrestrained spontaneously hypertensive rats. Drug Chem Toxicol 29: 2. 183-202
-
P Daull, A Blouin, M Beaudoin, S Gadbois, K Belleville, J Cayer, N Berthiaume, P Sirois, F Nantel, A Y Jeng, B Battistini (2006) The hemodynamic and metabolic profiles of Zucker diabetic fatty rats treated with a single molecule triple vasopeptidase inhibitor, CGS 35601. Exp Biol Med (Maywood) 231: 6. 824-829 Jun
-
P Daull, A Blouin, K Belleville, M Beaudoin, D Arsenault, H Leonard, P Sirois, F Nantel, A Y Jeng, B Battistini (2006) Triple VPI CGS 35601 reduces high blood pressure in low-renin, high-salt Dahl salt-sensitive rats. Exp Biol Med (Maywood) 231: 6. 830-833 Jun
Profile Details
https://www.linkedin.com/in/pierre-sirois-8990822b/?originalSubdomain=ca
http://publicationslist.org/pierre.sirois